Regeneron Pharmaceuticals' Change in Inventory fell 49.76% to $82.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $395.1 million, marking a year-over-year decrease of 28.07%. This contributed to the annual value of $619.7 million for FY2024, which is 128.08% up from last year.
Regeneron Pharmaceuticals' Change in Inventory amounted to $82.6 million in Q3 2025, which was up 94.35% from $42.5 million recorded in Q2 2025.
Over the past 5 years, Regeneron Pharmaceuticals' Change in Inventory peaked at $252.8 million during Q1 2021, and registered a low of -$31.3 million during Q2 2021.
Moreover, its 3-year median value for Change in Inventory was $100.4 million (2023), whereas its average is $106.3 million.
As far as peak fluctuations go, Regeneron Pharmaceuticals' Change in Inventory slumped by 119.25% in 2021, and later skyrocketed by 867.09% in 2022.
Regeneron Pharmaceuticals' Change in Inventory (Quarterly) stood at $163.7 million in 2021, then fell by 11.85% to $144.3 million in 2022, then slumped by 67.22% to $47.3 million in 2023, then skyrocketed by 148.84% to $117.7 million in 2024, then plummeted by 49.76% to $82.6 million in 2025.
Its Change in Inventory stands at $82.6 million for Q3 2025, versus $42.5 million for Q2 2025 and $152.3 million for Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value